Fund Overlap

See which holdings any two equity ETFs have in common, along with top differences in exposure.


For overlap across multiple ETFs use Portfolio Builder   

7

Number of overlapping holdings

17.9%

% of ARKG's 41 holdings also in XDNA

30.4%

% of XDNA's 23 holdings also in ARKG

Overlap by Weight
Sector Drift (ARKG minus XDNA)
Overlapping Holdings

Top 5 only shown here. Please log-in or sign up for a Basic (Free) membership to view the complete list.


Company Weight
in ARKG
Weight
in XDNA
Overlap
CRISPR THERAPEUTICS AG 8.6% 15.1% 8.6%
BEAM THERAPEUTICS, INC. 4.3% 13.7% 4.3%
INTELLIA THERAPEUTICS, INC. 3.3% 8.7% 3.3%
VERVE THERAPEUTICS, INC. 2.2% 4.5% 2.2%
VERTEX PHARMACEUTICALS INC 2.5% 1.5% 1.5%

Position Highlights (Non-Overlapping Exposures)
ARKG Overweight Relative to XDNA
RECURSION PHARMACEUTICALS, INC CLASS 6.7%
TWIST BIOSCIENCE CORP. 6.0%
EXACT SCIENCES CORP 5.9%
SCHRODINGER, INC. 4.5%
GINKGO BIOWORKS HOLDINGS INC CLASS A 4.0%
IONIS PHARMACEUTICALS, INC. 3.7%
ALCOBRA LTD 3.7%
10X GENOMICS INC CLASS A 3.7%
ACCOLADE, INC. 3.4%
PACIFIC BIOSCIENCES OF CALIF 3.4%
ARKG Underweight Relative to XDNA
THERMO FISHER SCIENTIFIC INC -9.5%
BEAM THERAPEUTICS, INC. -9.4%
CRISPR THERAPEUTICS AG -6.6%
EDITAS MEDICINE, INC. -5.7%
INTELLIA THERAPEUTICS, INC. -5.4%
CARIBOU BIOSCIENCES, INC. -4.7%
PRIME MEDICINE, INC. -4.4%
POSEIDA THERAPEUTICS, INC. -4.1%
ABBVIE INC -3.8%
ALLOGENE THERAPEUTICS, INC. -3.4%
Flag icons made by Freepik from www.flaticon.com is licensed by CC 3.0 BY